July 2016 HBV
Read online or forward
 
   
 

Enjoy today's HBV news!



Chronic hepatitis B virus (HBV) infection remains a global health problem with more than 1 million deaths per year, despite the existence and use of an efficient vaccine. In highly endemic areas, the coverage rate remains low and according to the World Health Organisation (WHO); 250 million people are chronic carriers.

Chronic HBV infection represents the first cause of hepatocellular carcinoma (HCC) worldwide. Antiviral drugs exist, but present either low viral suppression and side effects or resistance and require long-term administration. It was estimated that barely 10% of long-term follow-up patients on current treatments achieve HBsAg clearance.

The limitation of current treatments requires improved therapies meaning more innovative research.

Discover future EASL events on HBV

AASLD and EASL are joining forces to bring you the HBV treatment endpoints workshop, from discovery to regulatory approval, and welcome your abstract submissions.

It is critical to develop innovative research as we propel the field of hepatology and pursue a cure for hepatitis B. Don't miss this opportunity to share your research with peers and other key stakeholders.

Abstract submission deadline: 27 July 2016.
Read more.





Best of EASL will be stopping in New Delhi, India from 5-7 August, to take part in the INASL 2016 scientific programme packed with important topics including Hepatitis B.

We'll be onsite with the EASL booth, so drop by and say hello.



Unmet needs in Hepatology,
Paris, France, 27-28 October 2016

 
This clinical school will provide a balanced blend of lectures on theoretical, practical, and clinical case-based discussions, and includes a presentation on nucleo(s)tide analogues for hepatitis B.

Discover the scientific programme and send us your application before 29 July 2016 if you would like to attend.

 
Discover EASL funding 



Andrew K. Burroughs short-term training fellowship programme

EASL encourages and supports mobility across Europe in the aim to share research and knowledge.

Are you studying HBV?
Interested in taking your research to another level?

Young trainees and scientists are encouraged to apply for
the Andrew K. Burroughs short-term training fellowship programme.

Online application is now open!

Take the opportunity to visit other institutions and start new collaborations.
 
 
 

EASL
The Home of Hepatology

7 rue Daubin
CH 1203 Geneva
+41 22 807 03 60
www.easl.eu

This message is sent to <<Email Address>> - Why did I get this message

Update subscription preferences || Unsubscribe

You can sign in at any time by visiting the Newsletter section of our website.